Carna Biosciences, Inc.

Carna Biosciences, Inc.

CBIXF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$7.43B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Carna Biosciences, Inc.Carna Biosciences, Inc.-2.8-249%--2.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$7.43 Billion
Enterprise Value$8.78 Billion
Earnings per Share$-
Beta1.49
Outstanding Shares-

Return

Return on Equity248.62%ROE
Return on Assets-169.37%
Return on Invested Capital-196.39%

Valuation & Multiples

P/E Ratio-2.84P/E Ratio
PEG-30.82PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue11.6
Enterprise Value to EBIT-4.27
Enterprise Value to Net Income-4
Total Debt to Enterprise0.22
Debt to Equity-2.13Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Carna Biosciences, Inc.

61 employees
CEO: Kohichiro Yoshino

Carna Biosciences, Inc., established in Kobe, Japan in 2003, operates as a clinical-stage biopharmaceutical company. Its core focus is on discovering and developing novel drug treatments for significant unmet medical needs, particularly ...